In-house Lawyer
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›CRT spins out company to develop cancer surgery machine to melt tumours
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Project Development Manager or Business Development Manager (depending on experience)
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›K15
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›CYP 3A4
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›CYP 2E1
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›CYP 2D6
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›CYP 2A6
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›ASAP1
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›APC15
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›LIMD1
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›K15
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Call for Reagents
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Stephen Friend visits CRT to discuss Arch2POCM
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›FEATURE: CCR4 - from target discovery to a license and sponsored collaboration with Affitech
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›FEATURE: Successful Discovery Committee grant application shows promise for novel drug combinations
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›FEATURE: CRT reflects on a successful NCRI conference
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Small Molecule Tool for Reagent Use
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Fly Bottles
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›AUTM 2012
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Bio Europe Spring 2012
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›AACR Annual Meeting 2012
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›SYNbglA/beta-glucosidase
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›RalGDS
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›FNB6 hTERT
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Antioxidant Response Element - Nrf2 Reporter Line
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Gal4-p300
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›CRT appoints new Chairman to its Board of Directors
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Team Secretary/Personal Assistant
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›CRT and Cancer Research UK establish Lipid Metabolism Research Team
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Urothelium Marker
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Urothelium Marker
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Urothelium Marker
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Urothelium Marker
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Urothelium Marker
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Urothelium Marker
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Urothelium Marker
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Urothelium Marker
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Urothelium Marker
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›A2.9B4
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›A2.4B4
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›A2.2C11
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›A2.12A7
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›A2.10A12
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›PKC Epsilon -/-
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›CRT’s Discovery Laboratory Autotaxin programme progresses to Lead Optimisation
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›MISSION Therapeutics, a new spin-out, secures £6M in Series-A funding led by Sofinnova Partners
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Myatt, Stephen
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Head of Department - Functional Pharmacology
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›October 2011
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Preclinical Development Candidate selected for Chk1 Inhibitor Programme
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Technical Officer
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Scientist / Senior Scientist - Target Validation
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›GFP-KSC4 keratinocyte stem cell line
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›K38 Keratinocyte Cell Line
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›ASPP1
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›FEATURE: CRT pioneers new ways of generating exciting research and licensing discoveries
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›FEATURE: BliNK Therapeutics, our 24th spin-out company is formed
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›FEATURE: Abiraterone receives approval from FDA to be marketed as a prostate cancer therapy - Zytiga
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Scientist / Senior Scientists – Assay Development and Compound Profiling
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›BCL11A
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›July 2011
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Contracts Manager
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Interferon
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Interferon
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Interferon
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Interferon
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›CD22
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Keratin 7 & 8
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Keratin 7 & 8
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Keratin 17/18
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Keratin 19
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Neuroblastoma
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›HLA-DOB
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›CD33
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›phospho-cdc20
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›phospho-cdc20
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Gupta, Surbhi
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Parker, Elisabeth
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›CRT and Kurma Biofund to develop new antibody platform for translational research
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Fumarate hydratase conditional knockout mouse
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Academic Consortia
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Drug Discovery Alliances
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Cancer Metabolism
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›DNA Damage Response
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›New Type of Hormone Therapy Extends Prostate Cancer Patients’ Lives, Study Finds
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›CDP signs deal with Centella Therapeutics, Inc. to launch development of radiotherapy-enhancing drug
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›UNG KO
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›ULK1 WT MEF
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›ULK1 KO MEF
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›HEK293GFP-WIPI2
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›HEK293GFP-WIPI1
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Human Atg9 & Rat LC3 Cell Line
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Cancer Research Technology and Affitech A/S sign exclusive antibody development deal
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Mistry, Pritesh
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Senectus Therapeutics and AstraZeneca collaborate to identify triggers to cell ageing
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›CD70
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Desmoglein
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Positive Results in Genentech Ph II Clinical Trial of GDC-0449 in Advanced Basal Cell Carcinoma
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›Nanog
- At the forefront of advancing cancer discoveries
- Experts in the field, with a proven track record
- Putting patients before profit
Who we are
Leading translation company
CRT is the cancer-focused technology development and commercialisation arm of Cancer Research UK.
Find out more ›What we do
Sourcing & Developing cancer discoveries
Advancing discoveries to beat cancer and thus maximise patient benefit is at the heart of what we do.
Find out more ›Our track record
A proven record of success
CRT has a strong track record of successful drug discovery through collaboration and licensing.
Find out more ›Our History & Milestones
How it all began
From CRT's conception in 2002 up to 2010 and the announcement of our major industrial partnerships.
Find out more ›